A new classification system for primary lymphatic dysplasias based on phenotype

Clinical Genetics

Volumn 77, Issue 5, 2010, Pages 438-452

  Connell, F ^a   Brice, G ^b   Jeffery, S ^a   Keeley, V ^c   Mortimer, P ^b   Mansour, S ^a  

^a Medical Genetics   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CCBE1; FOXC2; Generalised; Lymphangiectasia; Lymphatic dysplasia; Lymphoedema distichiasis; Milroy disease; Phenotype classification; Primary lymphoedema; VEGFR3

Indexed keywords

TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SOX18; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CONGENITAL DISORDER; CYTOGENETICS; DISEASE CLASSIFICATION; GENE MUTATION; GENERALISED LYMPHATIC DYSPLASIA; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LYMPHEDEMA; MILROY DISEASE; MISSENSE MUTATION; ONSET AGE; PERICARDIAL EFFUSION; PHENOTYPE; PLEURA EFFUSION; PREVALENCE; PRIMARY LYMPHATIC DYSPLASIA; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYNDROMIC PRIMARY LYMPHEDEMA;

AGE OF ONSET; CHILD, PRESCHOOL; FACIES; FEMALE; HUMANS; INFANT; LYMPHEDEMA; MALE; PHENOTYPE; SYNDROME;

EID: 77953070816     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01394.x     Document Type: Article

References (54)

1. Mortimer PS. Managing lymphoedema. Clin Exp Dermatol 1995, 20:98-106.
2. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985, 76:206-218.
3. Jeltsch M, Tammela T, Alitalo K. Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res 2003, 314:69-84.
4. Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 2005, 21:457-483.
5. Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: new players. Trends Cell Biol 2005, 15:434-441.
6. Mäkinen T, Norrmén C, Petrova TV. Cell Mol Life Sci 2007, 64:1915-1929. Molecular mechanisms of lymphatic vascular development
7. Ferrell RE, Levinson KL, Esman JH. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 1998, 7:2073-2078.
8. Fang J, Dagenais SL, Erickson RP. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000, 67:1382-1388.
9. Irrthum A, Devriendt K, Chitayat D. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003, 72:1470-1478.
10. Ferrell RE, Kimak MA, Lawrence EC. Candidate gene analysis in primary lymphedema. Lymphat Res Biol 2008, 6:69-76.
11. Finegold DN, Schacht V, Kimak MA. HGF and MET mutations in primary and secondary lymphoedema. Lymph Res and Biol 2008, 6:65-68.
12. Connell F, Kalidas K, Ostergaard P. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet 2010, 127:231-241.
13. Alders M, Hogan BM, Gjini E. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 2009, 41(12):1272-1274.
14. Allen EV. Lymphoedema of the extremities. Classification, etiology and differential diagnosis: A study of three hundred cases. Arch Intern Med 1934, 54:606-624.
15. Kinmonth JB, Taylor GW, Tracey GD. Primary lymphoedema: Clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg 1957, 45:1-10.
16. Levine C. Primary disorders of the lymphatic vessels-a unified concept. J Pediatr Surg 1989, 24:233-240.
17. Browse NL, Stewart G. Lymphoedema: pathophysiology and classification. J Cardiovasc Surg 1985, 26:91-106.
18. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: A new clinical classification. Pediatrics 1990, 86:988-993.
19. Miller AJ, Bruna J, Beninson J. A universally applicable clinical classification of lymphedema. Angiology 1999, 50:189-192.
20. Shinawi M. Lymphedema of the lower extremity: is it genetic or nongenetic? Clin Pediatr 2007, 46:835-841.
21. Opitz JM. On congenital lymphedema. Am J Med Genet 1986, 24:127-129.
22. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-422.
23. Cohen MM. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 2006, 140:2013-2038.
24. Garzon MC, Huang JT, Enjolras O. Vascular malformations: Part I. J Am Acad Dermatol 2007, 56:353-370.
25. Garzon MC, Huang JT, Enjolras O. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 2007, 56:541-564.
26. Oduber C, van der Horst CM, Hennekam RCM. Klippel-Trenaunay Syndrome: Diagnostic Criteria and Hypothesis on Etiology. Ann Plast Surg 2008, 60:217-223.
27. Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet 2006, 14:1151-1157.
28. Connell FC, Ostergaard P, Carver C. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet 2009, 124(6):625-631.
29. http://www.lmdatabases.com/, London Dysmorphology database (Winter-Baraitser Dysmorphology Database), Last accessed on 2003.
30. Aagenaes O, Sigstad H, Bjorn-Hansen R. Lymphoedema in hereditary recurrent cholestasis from birth. Arch Dis Child 1970, 45:690-695.
31. Leung AK. Dominantly inherited syndrome of microcephaly and congenital lymphedema. Clin Genet 1985, 27:611-612.
32. Mucke J, Hoepffner W, Scheerschmidt G. Early onset lymphoedema, recessive form - a new form of genetic lymphoedema syndrome. Eur J Pediatr 1986, 145:195-198.
33. Hennekam RC, Geerdink RA, Hamel BC. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet 1989, 34:593-600.
34. Irons MB, Bianchi DW, Geggel RL. Possible new autosomal recessive syndrome of lymphedema, hydroceles, atrial septal defect, and characteristic facial changes. Am J Med Genet 1996, 66:69-71.
35. Glade C, van Steensel MA, Steijlen PM. Hypotrichosis, lymphedema of the legs and acral telangiectasias-new syndrome? Eur J Dermatol 2001, 11:515-517.
36. Doffinger R, Smahi A, Bessia C. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa-B signaling. Nat Genet 2001, 27:277-285.
37. Kreuter A, Hochdorfer B, Brockmeyer NH. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. Arch Dermatol 2008, 144(3):366-372.
38. Daniel-Spiegel E, Ghalamkarpour A, Spiegel R. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 2005, 25:1015-1018.
39. Ghalamkarpour A, Debauche C, Haan E. Sporadic in utero generalised edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. J Pediatr 2009, 155(1):90-93.
40. Jeffries GH, Chapman A, Sleisenger M. Low fat diet in intestinal lymphangiectasia. N Eng J Med 1964, 270:761-767.
41. Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis 2008, 3:5.
42. Dervendizi Sikova D, Pavlova LT, V'lckova Laskoska MT. Naevus varicosus osteohypertrophicus. An early diagnostic approach. Adv Exp Med Biol 1999, 455:535-540.
43. Furness PD, Bisignani G. Klippel-Trénaunay syndrome: 2 case reports and a review of genitourinary manifestations. J Urol 2001, 166:1418-1420.
44. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993, 6:204-218.
45. Connell FC, Homfray T, Thilaganthan B. Congenital vascular malformations: a series of five prenatally diagnosed cases. Am J Med Genet 2008, 146(20):2673-2680.
46. Milroy WF. An undescribed variety of hereditary oedema. New York Med J 1892, 56:503.
47. Brice G, Child AH, Evans A. Milroy disease and the VEGFR3 mutation phenotype. J Med Genet 2005, 42:98-102.
48. Carver C, Brice G, Mansour S. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet 2007, 71:187-189.
49. Ghalamkarpour A, Morlot S, Raas-Rothschild A. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations. Clin Genet 2006, 70:330-335.
50. Brice G, Mansour S, Bell R. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002, 39:478-483.
51. Petrova TV, Karpanen T, Norrmén C. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004, 10:974-981.
52. Mellor RH, Brice G, Stanton AW, French J. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007, 115:1912-1920.
53. van Steensel MA, Damstra RJ, Heitink M. Novel missense mutations in the FOXC2 gene alter transcriptional activity. Hum Mutat 2009, 30(12):E1002-E1009.
54. Rezaie T, Ghoroghchian R, Bell R. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2. Eur J Hum Genet 2008, 16:300-304.